farnesol has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, LCC; Carvalho, CRO; Matos, SL; Moreira, GV; Murata, GM | 1 |
| Kocarek, TA; Pant, A; Rondini, EA | 1 |
2 other study(ies) available for farnesol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice.
Topics: Animals; Bile Acids and Salts; Carbohydrates; Citrate (si)-Synthase; Collagen; Diet, High-Fat; Farnesol; Glucose; GTP-Binding Proteins; Humans; Insulin; Insulin Resistance; Kombucha Tea; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Phosphofructokinase-1; Proto-Oncogene Proteins c-akt; Serine; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha | 2022 |
Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Topics: Cell Line, Tumor; Constitutive Androstane Receptor; Farnesol; Fatty Acids; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidation-Reduction; PPAR alpha; Receptors, Cytoplasmic and Nuclear; Triglycerides | 2019 |